Surge in cataract surgeries fuels intraocular lens market to almost $1.4 billion

According to two new reports by iData Research (www.idataresearch.net), the leading global authority in medical device and pharmaceutical market research, growth in the use of optical coherence tomography (OCT) for the detection of ocular conditions will drive the U.S. diagnostic ophthalmic market to over $650 million by 2017. In addition, the U.S. contact lens market is expected to reach over $4.6 billion due to increased use of soft contact lenses and daily disposables by the aging baby-boomer generation. Companies such as Johnson & Johnson, CIBA Vision and CooperVision have emerged as the leading contact lens manufacturers in 2010.

"OCT sales slowed in 2009 due to the recession, however their use is growing in popularity among optometrists and ophthalmologists despite rising prices," says Dr. Douglas Fung, Analyst Manager at iData. "This growth is due to the technologies' superior resolution capabilities and ability to image the vascular structure under the retina. Physicians are expected to purchased second and third OCT units for their practices, leading to double-digit growth rates through 2013." 

iData's reports state that the non-mydriatic/mydriatic combination fundus camera segment was one of the fastest-growing in the diagnostic ophthalmic market, increasing at a CAGR of over 15% in 2010.

"Fundus cameras help to diagnose conditions such as diabetic eye disease, glaucoma and macular degeneration," says Dr. Fung. "The market is being driven by sales of combination devices from companies such as Topcon and Canon, which provide a cost-effective all-in-one solution."

iData's interventional ophthalmic report states moreover that the intraocular lens market is expected to reach almost $1.4 billion by 2017 due to advances in accommodative lenses that mimic the eye's natural ability to focus. Abbott's Synchrony® accommodative IOL is expected to gain FDA approval in 2011.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Advancing genomics research: An inside look at Azenta Life Sciences' new Oxford Genomics Laboratory